Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2023, 32(2):129-137

"FBI" tachycardia

Šimurda M
Arytmologické oddelenie, 1. Kardiologická klinika, Východoslovenský ústav srdcových a cievnych chorôb, a. s., Košice, Slovenská republika

The case report presents a case of preexcited atrial fibrillation, the so-called FBI (fastbroad-irregular) tachycardia. It discusses the characteristic ECG signs of this dysrhythmia, the diagnostic procedure, differential diagnosis and recommended acute and chronic management of patients with atrial fibrillation and accessory pathway.

Keywords: preexcited atrial fibrillation; FBI tachycardia; accessory pathway

Published: February 1, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šimurda M. "FBI" tachycardia. Cardiology Letters. 2023;32(2):129-137.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Morady F, Dicarlo LA Jr., Baerman JM, DE Buitleir M. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 1987;10:492-496. Go to original source...
    2. Sellers TD Jr, Bashore TM, Gallagher JJ. Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation. Circulation 1977;56:260-267. Go to original source...
    3. Boriani G, Biffi M, Frabetti L, Azzolini U, Sabbatani P, Bronzetti G, et al. Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. Am Heart J 1996;131:1214-1216. Go to original source...
    4. Schűtzenberger W, Leisch F, Gmeiner R. Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report. Int J Cardiol 1987;16:93-95. Go to original source...
    5. Tijunelis MA, Herbert ME. Myth: intravenous amiodarone is safe in patients with atrial fibrillation and Wolff-Parkinson-White syndrome in the emergency department. CJEM 2005; 7:262-265. Go to original source...
    6. Kappenberger LJ, Fromer MA, Steinbrunn W, Shenasa M, et al. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. Am J Cardiol 1984;54:330-335. Go to original source...
    7. Simonian SM, Lotfipour S, Wall Ch, Langdorf MI, et al. Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. Intern Emerg Med 2010;5:421-426. Go to original source...
    8. Ludmer PL, McGowan NE, Antman EM, Friedman PL, et al. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. J Am Coll Cardiol 1987;9:1357-1363. Go to original source...
    9. Boahene KA, Klein GJ, Yee R, Sharma AD, Fujimura O. Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. J Am Coll Cardiol 1990;16:14081414. Go to original source...
    10. Crijns HJGM, den Heijer P, van Wijk LM, Lie KI. Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome. Am Heart J 1988;115:13171321. Go to original source...
    11. Sharma AD, Klein GJ, Guiraudon GM, Milstein S. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway. Circulation 1985;1:161-169. Go to original source...
    12. Haissaguerre M, Fischer B, Labbé T, Lemétayer P, Montserrat P, d'Ivernois C, et al. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathway. Am J Cardiol 1992;69:493-497. Go to original source...
    13. Konoe A, Fukatani M, Tanigawa M, Isomoto S, Kadena M, Sakamoto T, et al. Electrophysiological abnormalities of the atrial muscle in patients with manifest Wolff-Parkinson-White syndrome associated with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1992;15:1040-1052. Go to original source...
    14. Peinado R, Merino JL, Gnoatto M, Angel Arias M. Atrial fibrillation triggered by postinfarction ventricular premature beats in a patient with Wolff-Parkinson-White syndrome. Europace 2005;7:221-224. Go to original source...
    15. Zhang Y, Wang L. Atrial vulnerability is a major mechanism of paroxysmal atrial fibrillation in patients with Wolff-ParkinsonWhite syndrome. Med Hypotheses 2006;67:1345-1347. Go to original source...
    16. Hsieh MH, Tai ChT, Chiang ChE, Tsai ChF, Chen YJ, Chan P. Double atrial potentials recorded in the coronary sinus in patients with Wolff-Parkinson-White syndrome: a possible mechanism of induced atrial fibrillation. J Interv Card Electrophysiol 2004;11:97-103. Go to original source...
    17. Kalarus Z, Kowalski O, Lenarczyk R, Prokopczuk J, Pasyk S. Electrophysiological features of orthodromic atrioventricular reentry tachycardia in patients with Wolff-Parkinson-White syndrome and atrial fibrillation. Pacing Clin Electrophysiol 2003;26:1479-1488. Go to original source...
    18. Soylu M, Demir AD, Ozdemir O, Soylu O, Topaloğlu S, Korkmaz S. Increased P wave dispersion after the radiofrequency catheter ablation in overt preexcitation patients: the role of atrial vulnerability. Int J Cardiol 2004;95:167-170. Go to original source...

    Return to the content